Skip to main content

Table 5 Baseline characteristics changes in 5-year follow-up survey of various rs1044250 genotypes in the Control group and the Mets group

From: Cross-talk between ANGPTL4 gene SNP Rs1044250 and weight management is a risk factor of metabolic syndrome

 

Control

Mets

CC (n = 174)

CT + TT (n = 28)

Total (n = 202)

CC (n = 667)

CT (n = 151)

TT (n = 13)

Total (n = 202)

Sex (male%)

47.7%

57.1%

49.0%

47.5%

39.7%

30.8%

45.9%

Age (years)

51.64 ± 9.30

51.07 ± 10.51

51.56 ± 9.45

51.42 ± 9.68

52.47 ± 10.20

54.00 ± 10.57

51.65 ± 9.79

ΔWeight (kg)

− 0.31 ± 1.64

− 0.52 ± 1.66

− 0.37 ± 1.64

− 2.11 ± 3.11

− 1.98 ± 2.78

− 1.90 ± 1.50

− 2.08 ± 3.03c

ΔBMI (kg/m2)

0.09 ± 0.86

− 0.02 ± 0.65

0.07 ± 0.84

− 0.55 ± 1.08

− 0.51 ± 1.00

− 0.46 ± 0.63

− 0.54 ± 1.06c

ΔWC (cm)

− 0.54 ± 3.02

− 0.98 ± 2.24

− 0.60 ± 2.92

− 4.37 ± 3.36

− 3.91 ± 3.08

− 4.27 ± 3.45

− 4.28 ± 3.31c

ΔSBP (mmHg)

1.07 ± 6.79

0.17 ± 5.53

0.95 ± 6.62

− 7.16 ± 13.39

− 6.90 ± 11.75

− 4.13 ± 8.09

− 7.06 ± 13.04c

ΔDBP (mmHg)

− 0.27 ± 2.53

0.38 ± 1.59

− 0.18 ± 2.43

− 5.46 ± 6.85

− 5.17 ± 6.69

− 4.97 ± 6.96

− 5.40 ± 6.82c

ΔTG (mmol/L)

0.32 ± 0.50

0.23 ± 0.58

0.31 ± 0.51

− 0.84 ± 1.81

− 0.70 ± 1.43

− 1.02 ± 1.90

− 0.82 ± 1.75c

ΔTC (mmol/L)

0.13 ± 1.08

− 0.08 ± 1.15

0.10 ± 1.09

− 0.33 ± 1.31

− 0.21 ± 1.33

− 0.75 ± 1.61

− 0.32 ± 1.32c

ΔHDL-c (mmol/L)

− 0.24 ± 0.48

− 0.09 ± 0.36

− 0.22 ± 0.46

− 0.25 ± 0.66

− 0.32 ± 0.64

− 0.83 ± 1.12a, b

− 0.27 ± 0.67

ΔFPG (mmol/L)

0.43 ± 1.42

0.59 ± 1.34

0.45 ± 1.41

− 0.12 ± 2.43

− 0.38 ± 2.53

− 0.10 ± 1.82

− 0.17 ± 2.44c

  1. Continuous variables are recorded by \(\stackrel{-}{x}\pm S\); Categorical variables are recorded in proportions
  2. Mets: metabolic syndrome; BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglyceride; TC: total cholesterol; HDL-c: high-density lipoprotein-cholesterol; FPG: fasting plasma glucose
  3. aStatistically significant compared with CC genotype in the Mets group
  4. bStatistically significant compared with CT genotype in the Mets group
  5. cStatistically significant compared with the Mets group; Δ, follow-up values minus baseline values